Coherus Oncology Inc. (CHRS)
NASDAQ: CHRS
· Real-Time Price · USD
1.58
-0.06 (-3.66%)
At close: Oct 01, 2025, 1:46 PM
-3.66% (1D)
| Bid | 1.58 |
| Market Cap | 184.22M |
| Revenue (ttm) | 142.77M |
| Net Income (ttm) | 179.75M |
| EPS (ttm) | 0.58 |
| PE Ratio (ttm) | 2.73 |
| Forward PE | -1.95 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.59 |
| Volume | 619,868 |
| Avg. Volume (20D) | 1,374,576 |
| Open | 1.60 |
| Previous Close | 1.64 |
| Day's Range | 1.55 - 1.63 |
| 52-Week Range | 0.66 - 2.43 |
| Beta | 0.89 |
| Ex-Dividend Date | n/a |
About CHRS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CHRS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CHRS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCoherus Oncology Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-19.11%
Coherus BioSciences shares are trading lower. The ...
Unlock content with
Pro Subscription
5 months ago
+16.59%
Coherus BioSciences shares are trading higher after the company announced it completed UDENYCA franchise divestiture.
